GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats


      • RYGB progressively decreases HF food preference in diet-induced obese Wistar rats
      • RYGB increases meal-induced GLP-1 and PYY release in diet-induced obese Wistar rats
      • Acute systemic administration of the selective GLP-1 receptor antagonist exendin-9 with the second-generation selective Y2 receptor antagonist JNJ-31020028 increases HF food preference additively in RYGB-operated but not in sham-operated diet-induced obese Wistar rats



      Roux-en-Y gastric bypass (RYGB) modifies various aspects of eating behavior in morbidly obese individuals to cause marked and lasting weight loss and improvements in metabolic health, but the underlying mechanisms remain poorly understood.


      To assess the relative contributions of the gut hormones glucagon-like peptide 1 (GLP-1) and peptide tyrosine tyrosine 3-36 (PYY3-36), whose circulating levels are enhanced by RYGB, in the reduced high-fat (HF) food preference that develops postoperatively.


      University hospital, Würzburg, Germany.


      HF diet–induced obese male Wistar rats underwent RYGB (n = 11) or sham (n = 7) surgeries and were subsequently maintained on a choice of low-fat (10% calories from fat) and HF (60% calories from fat) diets. From postoperative weeks 4 to 6, acute feeding studies were performed in which the selective GLP-1 receptor antagonist exendin-9 (30 μg/kg), the second-generation selective Y2 receptor antagonist JNJ-31020028 (10 mg/kg), or a combination of both drugs was administered intraperitoneally.


      During the observational period weight, adiposity and total food intake were lower while postprandial plasma GLP-1 and peptide tyrosine tyrosine levels were higher for RYGB-operated compared with sham-operated rats. There was a gradual shift in preference from HF to low-fat food in RYGB-operated rats by postoperative week 3. Single antagonist treatments had a relatively modest impact on HF food preference in rats from both surgical groups. However, dual antagonist treatment caused a striking increase in HF food preference specifically in RYGB-operated rats.


      GLP-1 and peptide tyrosine tyrosine 3-36 reduce HF food preference additively after RYGB supporting the use of gut hormone combination strategies for healthier feeding behavior.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Al-Najim W.
        • Docherty N.G.
        • le Roux C.W.
        Food intake and eating behavior after bariatric surgery.
        Physiol Rev. 2018; 98: 1113-1141
        • Gero D.
        • Steinert R.E.
        • le Roux C.W.
        • Bueter M.
        Do food preferences change after bariatric surgery?.
        Curr Atheroscler Rep. 2017; 19: 38
        • Thomas J.R.
        • Marcus E.
        High and low fat food selection with reported frequency intolerance following Roux-en-Y gastric bypass.
        Obes Surg. 2008; 18: 282-287
        • Zheng H.
        • Shin A.C.
        • Lenard N.R.
        • et al.
        Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery.
        Am J Physiol Regul Integr Comp Physiol. 2009; 297: R1273-R1282
        • Hao Z.
        • Mumphrey M.B.
        • Townsend R.L.
        • et al.
        Body composition, food intake, and energy expenditure in a murine model of Roux-en-Y gastric bypass surgery.
        Obes Surg. 2016; 26: 2173-2182
        • Hall K.D.
        • Bemis T.
        • Brychta R.
        • et al.
        Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity.
        Cell Metab. 2015; 22: 427-436
        • Molin Netto B.D.
        • Earthman C.P.
        • Farias G.
        • et al.
        Eating patterns and food choice as determinant of weight loss and improvement of metabolic profile after RYGB.
        Nutrition. 2017; 33: 125-131
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwan J.P.
        • et al.
        • for the STAMPEDE Investigators
        Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes.
        N Engl J Med. 2017; 376: 641-651
        • le Roux C.W.
        • Aylwin S.J.
        • Batterham R.L.
        • et al.
        Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
        Ann Surg. 2006; 243: 108-114
        • Shin A.C.
        • Zheng H.
        • Townsend R.L.
        • Sigalet D.L.
        • Berthoud H.R.
        Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery.
        Endocrinology. 2010; 151: 1588-1597
        • Steensels S.
        • Lannoo M.
        • Avau B.
        • et al.
        The role of nutrient sensing in the metabolic changes after gastric bypass surgery.
        J Endocrinol. 2017; 232: 363-376
        • Koda S.
        • Date Y.
        • Murakami N.
        • et al.
        The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.
        Endocrinology. 2005; 146: 2369-2375
        • Krieger J.P.
        • Arnold M.
        • Pettersen K.G.
        • Lossel P.
        • Langhans W.
        • Lee S.J.
        Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia.
        Diabetes. 2016; 65: 34-43
        • Ogawa N.
        • Ito M.
        • Yamaguchi H.
        • et al.
        Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain-hypothalamic neural pathways in rats.
        Metabolism. 2012; 61: 1312-1320
        • Shoblock J.R.
        • Welty N.
        • Nepomuceno D.
        • et al.
        In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.
        Psychopharmacology. 2010; 208: 265-277
        • Seyfried F.
        • Miras A.D.
        • Bueter M.
        • Prechtl C.G.
        • Spector A.C.
        • le Roux C.W.
        Effects of preoperative exposure to a high-fat versus a low-fat diet on ingestive behavior after gastric bypass surgery in rats.
        Surg Endosc. 2013; 27: 4192-4201
        • Hankir M.K.
        • Seyfried F.
        • Hintschich C.A.
        • et al.
        Gastric bypass surgery recruits a gut PPAR-α-striatal D1 R pathway to reduce fat appetite in obese rats.
        Cell Metab. 2017; 25: 335-344
        • Abegg K.
        • Schiesser M.
        • Lutz T.A.
        • Bueter M.
        Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
        Physiol Behav. 2013; 121: 70-78
        • Hao Z.
        • Townsend R.L.
        • Mumphrey M.B.
        • Patterson L.M.
        • Ye J.
        • Berthoud H.R.
        Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats.
        Obes Surg. 2014; 24: 2145-2151
        • Iwasaki Y.
        • Kakei M.
        • Nakabayashi H.
        • et al.
        Pancreatic polypeptide and peptide YY3-36 induce Ca2+ signaling in nodose ganglion neurons.
        Neuropeptides. 2013; 47: 19-23
        • Iwasaki Y.
        • Goswami C.
        • Yada T.
        Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons.
        Neuropeptides. 2017; 65: 77-82
        • Egerod K.L.
        • Petersen N.
        • Timshel P.N.
        • et al.
        Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms.
        Mol Metab. 2018; 12: 62-75
        • Neary N.M.
        • Small C.J.
        • Druce M.R.
        • et al.
        Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
        Endocrinology. 2005; 146: 5120-5127
        • Krieger J.P.
        • Langhans W.
        • Lee S.J.
        Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats.
        Physiol Behav. 2018; 192: 194-199
        • Nowak A.
        • Bojanowska E.
        Effects of peripheral or central GLP-1 receptor blockade on leptin-induced suppression of appetite.
        J Physiol Pharmacol. 2008; 59: 501-510
        • Radziszewska E.
        • Bojanowska E.
        Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
        Med Sci Monit Basic Res. 2013; 19: 6-11
        • Sheng K.
        • Zhang H.
        • Yue J.
        • et al.
        Anorectic response to the trichothecene T-2 toxin correspond to plasma elevations of the satiety hormone glucose-dependent insulinotropic polypeptide and peptide YY3-36.
        Toxicology. 2018; 402–403: 28-36
        • Williams D.L.
        • Hyvarinen N.
        • Lilly N.
        • et al.
        Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
        Physiol Behav. 2011; 103: 557-564
        • le Roux C.W.
        • Welbourn R.
        • Werling M.
        • et al.
        Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
        Ann Surg. 2007; 246: 780-785
        • Mathes C.M.
        • Bohnenkamp R.A.
        • le Roux C.W.
        • Spector A.C.
        Reduced sweet and fatty fluid intake after Roux-en-Y gastric bypass in rats is dependent on experience without change in stimulus motivational potency.
        Am J Physiol Regul Integr Comp Physiol. 2015; 309: R864-R874
        • Mathes C.M.
        • Letourneau C.
        • Blonde G.D.
        • le Roux C.W.
        • Spector A.C.
        Roux-en-Y gastric bypass in rats progressively decreases the proportion of fat calories selected from a palatable cafeteria diet.
        Am J Physiol Regul Integr Comp Physiol. 2016; 310: R952-R959
        • Saeidi N.
        • Nestoridi E.
        • Kucharczyk J.
        • Uygun M.K.
        • Yarmush M.L.
        • Stylopoulos N.
        Sleeve gastrectomy and Roux-en-Y gastric bypass exhibit differential effects on food preferences, nutrient absorption and energy expenditure in obese rats.
        Int J Obes. 2012; 36: 1396-1402
        • Eickhoff H.
        • Louro T.M.
        • Matafome P.N.
        • et al.
        Amelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile.
        Obes Surg. 2015; 25: 7-18
        • Carmody J.S.
        • Muñoz R.
        • Yin H.
        • Kaplan L.M.
        Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
        Am J Physiol Endocrinol Metab. 2016; 310: E855-E861
        • Osto E.
        • Doytcheva P.
        • Corteville C.
        • et al.
        Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
        Circulation. 2015; 131: 871-881
        • Ye J.
        • Hao Z.
        • Mumphrey M.B.
        • et al.
        GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.
        Am J Physiol Regul Integr Comp Physiol. 2014; 306: R352-R362
        • Svane M.S.
        • Jørgensen N.B.
        • Bojsen-Møller K.N.
        • et al.
        Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
        Int J Obes (Lond). 2016; 40: 1699-1706

      Linked Article

      • Comment on: GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats
        Surgery for Obesity and Related DiseasesVol. 15Issue 9
        • Preview
          While many studies over the past several years have begun to unravel the mechanisms behind the ability for Roux-en-Y gastric bypass surgery (RYGB) to elicit weight loss and metabolic improvement, it is yet unclear which aspects of the surgery lead to its therapeutic superiority to traditional lifestyle intervention (i.e., diet and exercise). While it is now accepted that gastric restriction is not a primary mechanism for RYGB’s effects on weight loss and ingestive behavior [1–3], it is important to understand the contribution of dietary composition and changes in macronutrient preference to the beneficial outcomes of the surgery.
        • Full-Text
        • PDF